As a patient at Medcare you can now benefit from a Cardiovascular Risk Assessment – determining your risk of developing heart disease and stroke over the next 10 years!

This Cardiovascular Risk Assessment uses the UK Qrisk assessment.

Take advantage of this invaluable check and take control of your health and future!

Who can have the Cardiovascular Risk Assessment?

It is available to anyone, but particularly relevant to those aged 40-74 who have NOT had a stroke, heart disease, diabetes or kidney disease.  Or for those over 65 who have an increased risk of dementia.

How will the assessment help you?

It will measure your risk of developing health problems. You are provided with a QRISK3 assessment. This is a prediction (based upon certain criteria like cholesterol, blood pressure, BMI etc) of the likelihood in your developing stroke or heart disease in the next 10 years. It has been developed over many years of research to help practitioners recognise risk factors in patients in order to provide ea

You will be given preventative advice. And as the tests can detect serious problems before they do any serious damage, you can look forward to a healthier and happier future.

What happens at the check?

  • It is performed by the practice nurse.
  • It only takes 20 minutes.
  • Lifestyle questionnaire including family history, social habits.
  • Height, weight and BMI are recorded.
  • Blood pressure checked.
  • ECG
  • Simple blood test for cholesterol and diabetes.
  • Dietary advice offered if necessary.
  • Risk factors assessed and results (including the results from the QRISK assessment) and advice given during follow-up doctor’s appointment (at 40 euros)

You can read more about cardiovascular disease here.

What is QRISK?

QRISK is an algorithm for predicting cardiovascular risk. It estimates the risk of a person developing cardiovascular disease (CVD) over the next 10 years and can be applied to those aged between 35 and 74 years.

It is based on UK data and includes additional risk factors, such as ethnicity, blood pressure treatment and body mass index.

QRISK®2-2012 was developed in the UK but is used internationally.  It is an updated version of the original QRISK® algorithm but now takes into account ethnicity and diabetes to help more accurately estimate the risk for each individual patient.

It is based on information collected between 1993 and 2010 and includes data on over 10 million patients registered with 550 general practices in the UK.  It is updated annually.  The algorithm includes information on the following risk factors:

  • Age
  • Sex
  • cholesterol/HDL ratio
  • blood pressure
  • diabetes
  • Smoking status
  • Self assigned ethnicity
  • Family History of premature coronary heart disease in a first degree relative under the age of 60
  • Deprivation (measured using the Townsend deprivation score)
  • Blood Pressure Treatment
  • Body Mass Index
  • Rheumatoid Arthritis
  • Chronic Kidney Disease
  • Atrial Fibrillation

A score of 10% or more indicates a need for further intervention to lower risk

What is the difference between QRISK®3 and QRISK®2?

QRISK®3 includes more factors than QRISK®2 to help enable doctors to identify those at most risk of heart disease and stroke.

These are;

  • Chronic kidney disease, which now includes stage 3 CKD
  • Migraine
  • Corticosteroids
  • Systemic lupus erythematosus (SLE)
  • atypical antipsychotics
  • severe mental illness
  • erectile dysfunction
  • a measure of systolic blood pressure variability

To book your  Cardiovascular Risk Assessment Call 966 860 258 or email doctors@medcarespain.com

The cost of the Cardiovascular Risk Assessment is 99 euros.